Boston Partners’s Omnicell OMCL Stock Holding History
Bought
Maintained
Sold
Other funds holding OMCL
NAMI
Boston Partners's OMCL Position: Q2 2026 in Review
Boston Partners reduced its Omnicell (OMCL) stake by 2.5% in Q2 2026, selling an estimated $530K and leaving 518,159 shares worth $21.9M. The position accounts for 0.02% of the portfolio, ranked #383.
Boston Partners first reported a position in OMCL in Q2 2013 and has held it in 12 quarters since. 307 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.
- Boston Partners held 518,159 shares of Omnicell worth $21.9M as of Q2 2026.
- Boston Partners sold 13,146 Omnicell shares in Q2 2026, an estimated $530K.
- Omnicell made up 0.02% of Boston Partners's portfolio in Q2 2026, its #383 holding.
- Boston Partners first reported a position in Omnicell in Q2 2013 and has held it in 12 quarters since.
- 307 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.
Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.